Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001013762-23-003900
Filing Date
2023-10-13
Accepted
2023-10-13 18:55:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2955
  Complete submission text file 0001013762-23-003900.txt   4455
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Lis William (Reporting) CIK: 0001574558 (see all company filings)

Type: 144

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39138 | Film No.: 231325956
SIC: 2836 Biological Products, (No Diagnostic Substances)